Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests if a mix of maqui berry extract and omega-3 fatty acids can lower inflammation in older, obese adults. Maqui berries have special plant pigments that reduce inflammation, and omega-3s are known for their anti-inflammatory effects. Maqui berries (Aristotelia chilensis) are known for their antioxidant, anticancer, and anti-inflammatory properties.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications, such as blood thinners, anti-inflammatory drugs, cardiovascular medications, lipid-altering drugs, and hormone replacement therapy, to participate in this trial.
Is the treatment with omega-3 fatty acids safe for humans?
How does the Maqui berry/omega-3 fatty acids treatment differ from other treatments?
This treatment is unique because it combines Maqui berry, known for its antioxidant properties, with omega-3 fatty acids, which have anti-inflammatory effects. This combination may offer a novel approach to reducing inflammation and oxidative stress, which are not typically addressed together in standard treatments.14678
What data supports the effectiveness of the treatment Maqui berry/omega-3 fatty acids?
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive maqui berry extract and omega-3 fatty acids or placebo for cytokine reduction
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Maqui berry/omega-3 fatty acids
- Placebos
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor